Low density lipoprotein oxidized in xanthoma tissue induces the formation and infiltration of foam cells

Journal of Dermatological Science

Volumn 30, Issue 3, 2002, Pages 248-255

  Hirata, Yasuhiko ^a   Okawa, Kozo ^a   Ikeda, Mitsunori ^a   Seike, Masahiro ^a   Matsumoto, Masaaki ^a   Kodama, Hajime ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Cholesterol; Foam cell; Macrophage; Oxidized low density lipoprotein; Xanthoma

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; M PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL TRANSFORMATION; CONTROLLED STUDY; DERMIS; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; FOAM CELL; INJECTION; INTERMETHOD COMPARISON; LIPID STORAGE; MACROPHAGE; NONHUMAN; OXIDATION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RABBIT; TISSUE LEVEL; UPREGULATION; XANTHOMA; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECT; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; MOUSE; PATHOLOGY; SKIN; XANTHOMATOSIS;

ANIMALS; FEMALE; FOAM CELLS; HUMANS; INJECTIONS, INTRADERMAL; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED BALB C; RABBITS; SKIN; XANTHOMATOSIS;

EID: 0036890107     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(02)00112-3     Document Type: Article

References (30)

1. Parthasarathy S., Steinberg D., Witztum J.L. The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:1992;219-225.
2. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
3. Steinbrecher U.P., Zhang H.F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 9:1990;155-168.
4. Kume N., Cybulsky M.I., Gimbrone M.J. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1992;1138-1144.
5. Kim J.A., Territo M.C., Wayner E., Carlos T.M., Parhami F., Smith C.W., Haberland M.E., Fogelman A.M., Berliner J.A. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14:1994;427-433.
6. Chisolm G.M. Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms. Lab. Invest. 68:1993;369-371.
7. Steinbrecher U.P. Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta. 1436:1999;279-298.
8. Parthasarathy S., Wieland E., Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 86:1989;1046-1050.
9. Heinecke J.W., Rosen H., Suzuki L.A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:1987;10098-10103.
10. Cathcart M.K., Chisolm G.M., McNally A.K., Morel D.W. Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60. In Vitro Cell. Dev. Biol. 24:1988;1001-1008.
11. Parthasarathy S., Printz D.J., Boyd D., Joy L., Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6:1986;505-510.
12. Steinbrecher U.P. Role of superoxide in endothelial-cell modification of low density lipoproteins. Biochim. Biophys. Acta. 959:1988;20-30.
13. Kodama H., Akiyama H., Nagao Y., Akagi O., Nohara N. Persistence of foam cells in rabbit xanthoma after normalization of serum cholesterol level. Arch. Dermatol. Res. 280:1988;108-113.
14. Kodama H., Nagao Y., Arakawa K., Tada J., Nohara N. Cholesterol synthesis and esterification in experimental xanthoma tissues. J. Lipid Res. 22:1981;1033-1041.
15. Hatch F.T. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;1-68.
16. Yagi K. Simple assay for the level of total lipid peroxides in serum or plasma. Meth. Mol. Biol. 108:1998;101-106.
17. Brown M.S., Goldstein J.L., Krieger M., Ho Y.K., Anderson R.G. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82:1979;597-613.
18. St Clair R.W., Smith B.P., Wood L.L. Stimulation of cholesterol esterification in rhesus monkey arterial smooth muscle cells. Circ. Res. 40:1977;166-173.
19. Cathcart M.K., McNally A.K., Morel D.W., Chisolm G.M. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. J. Immunol. 142:1989;1963-1969.
20. Rankin S.M., Parthasarathy S., Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32:1991;449-456.
21. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74:1984;1890-1894.
22. Leake D.S., Rankin S.M. The oxidative modification of low density lipoproteins by macrophages. Biochem. J. 270:1990;741-748.
23. Lamb D.J., Mitchinson M.J., Leake D.S. Transition metal ions within human atherosclerotic lesions can catalyse the oxidation of low density lipoprotein by macrophages. FEBS Lett. 374:1995;12-16.
24. Ylä-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
25. Rosenfeld M.E., Palinski W., Ylä-Herttuala S., Butler S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
26. Palinski W., Rosenfeld M.E., Ylä-Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
27. Hoff H.F., O'Neil J. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. Atherosclerosis. 70:1988;29-41.
28. Morton R.E., West G.A., Hoff H.F. A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. J. Lipid Res. 27:1986;1124-1134.
29. Daugherty A., Zweifel B.S., Sobel B.E., Schonfeld G. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 8:1988;768-777.
30. Quinn M.T., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84:1987;2995-2998.